---
title: "Glucocorticoid signaling and microRNA networks in acute lymphoblastic leukemia: GAO078 model findi"
id: "pubmed-43059396"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-43059396"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/43059396/"
doi: "10.3892/ijo.2026.5963"
published_at: "2026-11-20T12:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Glucocorticoid signaling and microRNA networks in acute lymphoblastic leukemia: GAO078 model findi
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-43059396
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/43059396/)
- **DOI:** [10.3892/ijo.2026.5963](https://doi.org/10.3892%2Fijo.2026.5963)
- **Published At:** 2026-11-20T12:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- The investigators expanded a prior Boolean network (GEB052) by adding 26 microRNAs, producing an updated model named GAO078 with 78 nodes and 274 edges. - GAO078 improved correct prediction rates compared with the earlier model, according to the authors; specific accuracy metrics were not reported in the abstract. - Dependency matrix and DRUGSURV analyses were applied to the model. These computational approaches, combined with laboratory validation, identified **STAT5B** as an important control node linking glucocorticoids to apoptotic outputs. - The study team tested the tyrosine kinase inhibitor **dasatinib** (a known inhibitor of ABL and targeting STAT5B) in ALL cell lines and observed selective efficacy for **glucocorticoid-resistant** cells. - Cytotoxic activity of dasatinib was seen in BCR‑ABL–negative leukemic cells in vitro; the authors stated this finding warrants further testing before clinical application. - GAO078 analysis flagged **miR-27a**, **miR-20a** and **miR-9** as frequently featured and of clinical significance; these miRs are predicted to target nuclear receptor coactivators and corepressors. - Laboratory work on dexamethasone plus dasatinib–treated ALL cells showed increased expression of miR-27a, miR-20a and miR-9, per the abstract. - The investigators concluded that crosstalk between the **glucocorticoid receptor** signaling and microRNA networks influences cell fate decisions and that a systems biology approach can help identify routes to reduce glucocorticoid resistance and guide future therapeutic evaluation. - The abstract did not report detailed methods (cell lines used, dosing, sample sizes), numerical performance metrics for model prediction, or in vivo/clinical data; the authors noted the need for further testing of dasatinib in BCR‑ABL–negative ALL cells.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/43059396/#article-details) ### NIH Websites Are Changing * [Get the Latest Updates and FAQs on the transition](https://www.nih.gov/web-modernization) * Per [Executive Order 14434](https://www.whitehouse.gov/presidential-actions/2026/09/inaugurating-the-era-of-super-intelligence/), federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition. ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43059396%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/43059396/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/43059396/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/43059396/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/43059396/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/43059396/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/43059396/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43059396%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43059396%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/43059396/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43059396/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43059396/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/43059396/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43059396/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/43059396/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/43059396/#abstract) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/43059396/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/43059396/#substances) Title & authors Abstract MeSH terms Substances Int J Oncol Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Int+J+Oncol%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Int+J+Oncol%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059396/) . 2026 Dec;69(6):150. doi: 10.3892/ijo.2026.5963. Epub 2026 Nov 20. # Modelling and analysis of glucocorticoid action in acute lymphoblastic leukemia [Aisha Othman](https://pubmed.ncbi.nlm.nih.gov/?term=Othman+A&cauthor_id=43059396)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43059396/#full-view-affiliation-1 "School of Science, Engineering and Environment, University of Salford, Salford, Manchester M5 4WT, UK."), [Hend Alrasheedi](https://pubmed.ncbi.nlm.nih.gov/?term=Alrasheedi+H&cauthor_id=43059396)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43059396/#full-view-affiliation-2 "School of Health Sciences, University of Manchester, Manchester M13 9PL, UK."), [Muhammad-Nurudeen Nurudeen](https://pubmed.ncbi.nlm.nih.gov/?term=Nurudeen+MN&cauthor_id=43059396)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43059396/#full-view-affiliation-1 "School of Science, Engineering and Environment, University of Salford, Salford, Manchester M5 4WT, UK."), [Delta Patricia Menendez Creamer](https://pubmed.ncbi.nlm.nih.gov/?term=Menendez+Creamer+DP&cauthor_id=43059396)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43059396/#full-view-affiliation-1 "School of Science, Engineering and Environment, University of Salford, Salford, Manchester M5 4WT, UK."), [Alireza Fatahian](https://pubmed.ncbi.nlm.nih.gov/?term=Fatahian+A&cauthor_id=43059396)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43059396/#full-view-affiliation-1 "School of Science, Engineering and Environment, University of Salford, Salford, Manchester M5 4WT, UK."), [Constantinos Demonacos](https://pubmed.ncbi.nlm.nih.gov/?term=Demonacos+C&cauthor_id=43059396)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43059396/#full-view-affiliation-2 "School of Health Sciences, University of Manchester, Manchester M13 9PL, UK."), [Athar Aziz](https://pubmed.ncbi.nlm.nih.gov/?term=Aziz+A&cauthor_id=43059396)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43059396/#full-view-affiliation-1 "School of Science, Engineering and Environment, University of Salford, Salford, Manchester M5 4WT, UK."), [Marija Krstic-Demonacos](https://pubmed.ncbi.nlm.nih.gov/?term=Krstic-Demonacos+M&cauthor_id=43059396)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43059396/#full-view-affiliation-1 "School of Science, Engineering and Environment, University of Salford, Salford, Manchester M5 4WT, UK."), [Emyr Yosef Bakker](https://pubmed.ncbi.nlm.nih.gov/?term=Bakker+EY&cauthor_id=43059396)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/43059396/#full-view-affiliation-3 "School of Medicine and Dentistry, University of Lancashire, Preston PR1 2HE, UK.") Affiliations Expand ### Affiliations * 1 School of Science, Engineering and Environment, University of Salford, Salford, Manchester M5 4WT, UK. * 2 School of Health Sciences, University of Manchester, Manchester M13 9PL, UK. * 3 School of Medicine and Dentistry, University of Lancashire, Preston PR1 2HE, UK. * PMID: **43059396** * DOI: [ 10.3892/ijo.2026.5963 ](https://doi.org/10.3892/ijo.2026.5963) Item in Clipboard # Modelling and analysis of glucocorticoid action in acute lymphoblastic leukemia Aisha Othman et al. Int J Oncol. 2026 Dec. Show details Display options Display options Format Abstract PubMed PMID Int J Oncol Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Int+J+Oncol%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Int+J+Oncol%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059396/) . 2026 Dec;69(6):150. doi: 10.3892/ijo.2026.5963. Epub 2026 Nov 20. ### Authors [Aisha Othman](https://pubmed.ncbi.nlm.nih.gov/?term=Othman+A&cauthor_id=43059396)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43059396/#short-view-affiliation-1 "School of Science, Engineering and Environment, University of Salford, Salford, Manchester M5 4WT, UK."), [Hend Alrasheedi](https://pubmed.ncbi.nlm.nih.gov/?term=Alrasheedi+H&cauthor_id=43059396)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43059396/#short-view-affiliation-2 "School of Health Sciences, University of Manchester, Manchester M13 9PL, UK."), [Muhammad-Nurudeen Nurudeen](https://pubmed.ncbi.nlm.nih.gov/?term=Nurudeen+MN&cauthor_id=43059396)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43059396/#short-view-affiliation-1 "School of Science, Engineering and Environment, University of Salford, Salford, Manchester M5 4WT, UK."), [Delta Patricia Menendez Creamer](https://pubmed.ncbi.nlm.nih.gov/?term=Menendez+Creamer+DP&cauthor_id=43059396)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43059396/#short-view-affiliation-1 "School of Science, Engineering and Environment, University of Salford, Salford, Manchester M5 4WT, UK."), [Alireza Fatahian](https://pubmed.ncbi.nlm.nih.gov/?term=Fatahian+A&cauthor_id=43059396)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43059396/#short-view-affiliation-1 "School of Science, Engineering and Environment, University of Salford, Salford, Manchester M5 4WT, UK."), [Constantinos Demonacos](https://pubmed.ncbi.nlm.nih.gov/?term=Demonacos+C&cauthor_id=43059396)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43059396/#short-view-affiliation-2 "School of Health Sciences, University of Manchester, Manchester M13 9PL, UK."), [Athar Aziz](https://pubmed.ncbi.nlm.nih.gov/?term=Aziz+A&cauthor_id=43059396)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43059396/#short-view-affiliation-1 "School of Science, Engineering and Environment, University of Salford, Salford, Manchester M5 4WT, UK."), [Marija Krstic-Demonacos](https://pubmed.ncbi.nlm.nih.gov/?term=Krstic-Demonacos+M&cauthor_id=43059396)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43059396/#short-view-affiliation-1 "School of Science, Engineering and Environment, University of Salford, Salford, Manchester M5 4WT, UK."), [Emyr Yosef Bakker](https://pubmed.ncbi.nlm.nih.gov/?term=Bakker+EY&cauthor_id=43059396)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/43059396/#short-view-affiliation-3 "School of Medicine and Dentistry, University of Lancashire, Preston PR1 2HE, UK.") ### Affiliations * 1 School of Science, Engineering and Environment, University of Salford, Salford, Manchester M5 4WT, UK. * 2 School of Health Sciences, University of Manchester, Manchester M13 9PL, UK. * 3 School of Medicine and Dentistry, University of Lancashire, Preston PR1 2HE, UK. * PMID: **43059396** * DOI: [ 10.3892/ijo.2026.5963 ](https://doi.org/10.3892/ijo.2026.5963) Item in Clipboard Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract Glucocorticoids (GCs) induce apoptosis in leukocytes and remain a cornerstone of acute lymphoblastic leukemia (ALL) therapy, though resistance and toxicity remain problems. GEB052, a previously published Boolean model of the glucocorticoid receptor (GR) and its connected proteins, input (GC) and outputs (cell death and inflammation), generated insight into glucocorticoid resistance. The present study improved the model's predictive capacity through the inclusion of 26 microRNAs (miRs), resulting in a new model: GAO078 (78 nodes, 274 edges). GAO078 demonstrated improved correct prediction rates compared with GEB052, while dependency matrix and DRUGSURV analyses, together with laboratory validation, identified signal transducer and activator of transcription 5B (STAT5B) as an important level of control linked to GCs and apoptosis. The tyrosine kinase inhibitor dasatinib (DAS), which targets STAT5B and conventionally targets break point cluster (BCR)‑Abelson tyrosine kinase gene (ABL), was shown in ALL cell lines to have selective efficacy for GC‑resistant cells. Notably, cytotoxicity was demonstrated for BCR‑ABL‑negative leukemic cells, suggesting the potential for the use of DAS in this type of leukemia cells, upon further testing. GAO078 model analysis also identified miR‑27a, miR‑20a and miR‑9 to feature frequently and have clinical significance. Laboratory analysis of dexamethasone/DAS‑treated ALL cells showed an increase in the expression of these miRs. All three miRs are predicted to target nuclear receptor coactivators and corepressors; therefore, the outcome on nuclear receptor action could be a balance between multiple, complex networks. The findings of the present study demonstrate the significance of GR signaling and microRNA crosstalk in the determination of cell fate and emphasize the value of a systems biology approach in helping to identify routes towards reducing GC resistance and potentially improving future leukemia treatment. **Keywords:** acute lymphoblastic leukemia; bioinformatics; glucocorticoid receptor; miRNAs. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## MeSH terms * Apoptosis / drug effects Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Apoptosis%2Fdrug+effects%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Apoptosis) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059396/) * Cell Line, Tumor Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Cell+Line%2C+Tumor%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Cell+Line%2C+Tumor) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059396/) * Drug Resistance, Neoplasm / drug effects Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Drug+Resistance%2C+Neoplasm%2Fdrug+effects%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Drug+Resistance%2C+Neoplasm) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059396/) * Drug Resistance, Neoplasm / genetics Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Drug+Resistance%2C+Neoplasm%2Fgenetics%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Drug+Resistance%2C+Neoplasm) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059396/) * Glucocorticoids* / pharmacology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Glucocorticoids%2Fpharmacology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Glucocorticoids) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059396/) * Glucocorticoids* / therapeutic use Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Glucocorticoids%2Ftherapeutic+use%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Glucocorticoids) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059396/) * Humans Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Humans%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Humans) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059396/) * MicroRNAs / genetics Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22MicroRNAs%2Fgenetics%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=MicroRNAs) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059396/) * MicroRNAs / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22MicroRNAs%2Fmetabolism%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=MicroRNAs) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059396/) * Models, Biological Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Models%2C+Biological%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Models%2C+Biological) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059396/) * Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Precursor+Cell+Lymphoblastic+Leukemia-Lymphoma%2Fdrug+therapy%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Precursor+Cell+Lymphoblastic+Leukemia-Lymphoma) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059396/) * Precursor Cell Lymphoblastic Leukemia-Lymphoma* / genetics Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Precursor+Cell+Lymphoblastic+Leukemia-Lymphoma%2Fgenetics%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Precursor+Cell+Lymphoblastic+Leukemia-Lymphoma) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059396/) * Precursor Cell Lymphoblastic Leukemia-Lymphoma* / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Precursor+Cell+Lymphoblastic+Leukemia-Lymphoma%2Fmetabolism%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Precursor+Cell+Lymphoblastic+Leukemia-Lymphoma) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059396/) * Precursor Cell Lymphoblastic Leukemia-Lymphoma* / pathology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Precursor+Cell+Lymphoblastic+Leukemia-Lymphoma%2Fpathology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Precursor+Cell+Lymphoblastic+Leukemia-Lymphoma) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059396/) * Receptors, Glucocorticoid* / genetics Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Receptors%2C+Glucocorticoid%2Fgenetics%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Receptors%2C+Glucocortico
## Related Clinical Research

- [PIP4K2A depletion reduces AKT signaling and increases chemotherapy sensitivity in T‑cell lymphobla](https://medichelpline.com/clinical-feed/pubmed-42570494.md) (DOI: 10.1016/j.bbrc.2026.154404)
- [Selinexor plus bortezomib, lenalidomide, dexamethasone (XVRd) in newly diagnosed high‑risk multipl](https://medichelpline.com/clinical-feed/pubmed-42544613.md) (DOI: 10.1080/07853890.2026.2703403)
- [Aggressive NK‑cell Leukemia with HLH and Organ Failure Bridged to Allogeneic HSCT — Case Report](https://medichelpline.com/clinical-feed/frontiers-in-immunology-15-case-report-fulminant-aggressive-nk-cell-leukemia-with-hemophagocytic.md)
- [Multiomic predictors of minimal residual disease after Isa-KRd induction in newly diagnosed multip](https://medichelpline.com/clinical-feed/nature-1-molecular-predictors-of-minimal-residual-disease-in-newly-diagnosed-multiple.md)
- [PLOS One Editorial Note: Concerns Raised Over Dexamethasone Study Figures](https://medichelpline.com/clinical-feed/plos-one-20-editorial-note-dexamethasone-alleviates-tumor-associated-brain-damage-and.md)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.